FS Thx for clarifying that . I briefly asked if they were prescribing Auryxia in her dept . To her knowledge only 1 patient was on it as insurance providers demanded patient fail existing treatments first and required extensive paper work to enable a switch .
Will try and get more detail this evening . The 2 CKD drugs in development that her Dept seemed most interested in, are being developed by FGEN and OMER
News 
Market Data 
Discover 
